Rite Aid extends hours for last-minute shopping
CAMP HILL, Pa. — Rite Aid is extending store hours and featuring gift items as the holiday shopping season comes to an end, the retail pharmacy chain said Friday.
The company said it would extend store hours through Monday, as well as keeping some stores open on Christmas Eve and Christmas Day, including some 24-hour stores.
"Whether you’ve just begun to shop or are at the end of your list, Rite Aid has a range of gifts that are perfect for your gift-giving needs," Rite Aid EVP merchandising Tony Montini said. "And with our nearly 4,600 locations nationwide operating under extended hours, people can quickly and easily cross names off their list and feel good about their giving."
In addition to items like batteries, tree trimmings and wrapping paper, stores will stock candy, toys, gift cards, electronics and bath and beauty items.
E’Shee introduces new eye cream
PHILADELPHIA — E’Shee Clinical Esthetic on Thursday announced the launch of Alpha and Omega, a new gene-therapy eye cream product designed to target wrinkles, dark circles, puffiness and sagging skin.
The cream has a light, creamy texture and includes a blend of ingredients like aFGF (acidic fibroblast growth factor), far-infrared powder and peptides. The cream also works to reduce redness associated with rosacea and helps to repair broken capillaries. It can also help to heal scar tissue left behind by burns or acne.
"Supremely-advanced restoration and care for the eyes and lips is what this product delivers," Nataly Giter, founder, E’shee Clinical Esthetic, said of Alpha and Omega.
The product is recommended for all skin types and ages and it’s non-greasy, fast-absorbing formula means no clogged pores for consumers.
Meda enters OTC oral care arena with acquisition of ZpearPoint AS
GÖTEBORG, Sweden — Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion.
The EB24 product is based on hydrogen fluoride highly diluted in water. In studies, the product has shown that it is able to penetrate enamel surfaces and form calcium fluoride resulting in an anti-erosive effect. As such, EB24 works as a protective agent against dental erosion.
"EB24 will be an important addition to our OTC product portfolio and an excellent complement to CB12," said Jörg-Thomas Dierks, CEO of Meda AB. "The acquisition enables us to continue to build on our OTC offering and adds to future growth."
The EB24 product is expected to be launched in the first half of 2015 as a mouth rinse. Patents valid until 2025 have been approved in Europe and are pending in the United States.
The purchase price will amount to $11.7 million over time and is dependent on various milestones, such as launch and approvals. Meda also will pay a low, single-digit percentage on sales, the company added.